Contact us to learn more about

our Premium Content: News alerts, weekly reports and conference planners

BIOMARKER:

NRAS overexpression

Contact us to learn more about our Premium Content:

News alerts, weekly reports and conference planners

Entrez ID:

Related biomarkers:

‹

›

NRAS overexpression	Uveal Melanoma	NRAS overexpression	Uveal Melanoma	selumetinib Resistant: C3 – Early Trials selumetinib Resistant : C3	selumetinib Resistant: C3 – Early Trials selumetinib Resistant : C3
NRAS overexpression	Melanoma	NRAS overexpression	Melanoma	vemurafenib Resistant: C3 – Early Trials vemurafenib Resistant : C3	vemurafenib Resistant: C3 – Early Trials vemurafenib Resistant : C3
NRAS overexpression	Colorectal Cancer	NRAS overexpression	Colorectal Cancer	cetuximab + vemurafenib Resistant: D – Preclinical cetuximab + vemurafenib Resistant : D	cetuximab + vemurafenib Resistant: D – Preclinical cetuximab + vemurafenib Resistant : D
NRAS overexpression	Melanoma	NRAS overexpression	Melanoma	DEL-22379 Sensitive: D – Preclinical DEL-22379 Sensitive : D	DEL-22379 Sensitive: D – Preclinical DEL-22379 Sensitive : D